ARTICLES

ZengSQ, Halkosalo A, Salminen M, Szakal ED, Karvonen A, and Vesikari T,  Norovirus Gastroenteritis in Young Children Receiving Human Rotavirus Vaccine. Scandinavian Journal of Infectious Diseases.2010 July.

ZengSQ, Halkosalo A, Salminen M, Szakal ED, Puustinen L, Vesikari T.One-step quantitative RT-PCR for the detection of rotavirus in acute gastroenteritis.J Virol Methods. 2008 Nov;153(2):238-40. Epub 2008 Sep.

VesikariT, Karvonen A, Puustinen L, Szakal ED, Zeng SQ, Delem A, De Vos B. Ashort report on highlights of world-wide development of RIX4414: An Europeanexperience. online Vaccine 2005 Aug Vaccine 24 2006.

VesikariT, Karvonen A, Puustinen L, Szakal ED, Zeng SQ, Delem A, De Vos B. 2004.Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.ThePediatric Infectious Disease Journal Volume 23, Number 10, October 2004. (cited:130)

Szakál D, Pál T. Comparison of media for the selective culture of enteroinvasive Escherichia coli. European Journal of Clinical Microbiology and Infectious Diseases 2003, 22: 235-241. (cited: 1)

Szakál D, Gadó I, Pál T. A colony blot immunoassay to detect enteroinvasive Escherichia coli and Shigella in water samples. Journal of Applied Microbiology 2001, 90 (2): 229-236

SUPPORT

Vesikari T et al and the Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006 Jan5;354(1):23-33.

Ruiz-Palacios GM et al and the Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.N Engl J Med. 2006 Jan5; 354(1):11-22.

PRESENTATIONS

Szakal ED, Halkosalo A, Salminen M, Zeng SQ, Karvonen A,Vesikari T. Human calicivirus in children with gastroenteritis in a rotavirusvaccine trial in Finland. Oral presentation. Third International CalicivirusConference  Nov 2007 - Cancun, Mexico

Szakal ED, Zeng SQ, S Räsänen, M Salminen, I Djatchkova, LPuustinen, A Haloksalo, A Karvonen, A Delem, A Poliszczack, JP Cassart, B DeVos, T Vesikari. Rotavirus RNAemia in rotavirus vaccine recipients andin infants with wild type rotavirus infection. Oral presentation. 2nd EuropeanRotavirus Biology Meeting, June 2007 - Stockholm, Sweden

Szakal ED, Zeng SQ, S Räsänen, M Salminen, I Djatchkova, LPuustinen, A Haloksalo, A Karvonen, A Delem, A Poliszczack, JP Cassart, B DeVos, T Vesikari. Rotavirus RNAemia in rotavirus vaccine recipients andi n infants with wild type rotavirus infection. Oral presentation. Rotavirus Antigenaemia, RNAemia and Viraemia Round Table Meeting, April 2007- Lisbon, Portugal

HLiu; M Dong; LL Yang; ED Szakal; S Allen; SC Hall; SJ Fisher; TC Hazen; JTGeller; ME Singer; J Jin; MD Biggin; HE Witkowska. Development and Refinementof an iTRAQ-Based “Tagless” Strategy for High-Throughput Purification and Identification of Soluble Protein Complexes; American Society for MassSpectrometry Annual Meeting 2010. Poster 135. Session: Proteomics: NewApproaches II.

Ming D et al. Protein Complex Analysis Project (PCAP): Protein Complex Purification and Identification by ”Tagless” Strategy. Poster. Abstract p.157. February 2009, Bethesda, MD. Genomics: GTL Contractor-Grantee Workshop VII, USDA-DOE Plant Feedstock Genomics for Bioenergy Awardee Workshop 2009.

Allen S et al. Protein Complex Analysis Project (PCAP): Multi-ProteinComplex Purification and Identification by Mass Spectrometry. Poster 119 North Bethesda, MD. Genomics: GTL Contractor-Grantee Workshop VI. and Metabolic Engineering Working Group Interagency Conference on Metabolic Engineering 2008

CITATIONS

"Rotavirus RNAemia in rotavirus vaccine recipients and in infants with wild type rotavirus infection" was cited

in Rotavirus Biology Meeting Report, and in the manufacturer's Press Release.